FRANKLIN LAKES, N.J. , Oct.
30, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX ), a leading global medical technology company, today launched the new BD® Intraosseous Vascular Access System, enabling access for rapid delivery of fluids or medication in critical emergency situations. The procedure involves inserting a needle into the bone marrow cavity when intravenous (IV) access is challenging or delayed. The BD® IO System can quickly provide access to the circulatory system for adult and pediatric patients and is built for rapid intervention in varied emergent care environments.
The BD® IO System is the only IO device on the market that can be placed after the extension set is attached and the only with integrated passive needle tip safety, designed to protect care providers and patients against needlestick injuries. Clinicians can stabilize the device on the contours of any surrounding anatomy and select from five needle lengths to accommodate a broad range of patients. Unlike other devices on the market, the powered driver features a rechargeable battery, which extends the life of the drill up to 12 times when compared to non-rechargeable competitive drills.
Its unique multi-light battery indicator provides an instant indication of battery status so clinicians can be confident the drill is powered for the procedure. "In emergency situations, mistakes and delays can have devastating consequences," said Eric Borin, worldwide president of Medication De.